Two new antivirals for HIV will be approved soon

Two new antivirals for HIV will be approved soon...Rescriptor (delavirdine) and Viracept (nelfinavir).

Rescriptor will be the second non-nucleoside reverse transcriptase inhibitor (NNRTI)...similar to Viramune (nevirapine).

The NNRTIs aren't as powerful as the protease inhibitors. But they have a niche in combo therapy...by boosting the efficacy of nucleosides such as AZT (Retrovir), 3TC (Epivir), etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote